| scholarly article | Q13442814 |
| P50 | author | Nemat Khan | Q47159658 |
| Arjun Muralidharan | Q85074407 | ||
| P2093 | author name string | Maree T Smith | |
| P2860 | cites work | Neurotrophins and Neuropathic Pain: Role in Pathobiology | Q28084413 |
| Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis | Q28085455 | ||
| Angiotensin II type 2 receptor mediates programmed cell death | Q28272739 | ||
| Quantitative assessment of tactile allodynia in the rat paw | Q29617366 | ||
| Clinical pharmacology of analgesics assessed with human experimental pain models: bridging basic and clinical research | Q30443497 | ||
| T-cell infiltration and signaling in the adult dorsal spinal cord is a major contributor to neuropathic pain-like hypersensitivity. | Q33619939 | ||
| Western blot: technique, theory, and trouble shooting | Q34304981 | ||
| EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial | Q34403098 | ||
| A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. | Q34554719 | ||
| Commercially available angiotensin II At₂ receptor antibodies are nonspecific. | Q34809342 | ||
| ETA activation mediates angiotensin II-induced infiltration of renal cortical T cells. | Q35647856 | ||
| The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain | Q35669849 | ||
| Mechanisms underlying clinical efficacy of Angiotensin II type 2 receptor (AT2R) antagonist EMA401 in neuropathic pain: clinical tissue and in vitro studies | Q35786784 | ||
| Antiallodynic effects of alpha lipoic acid in an optimized RR-EAE mouse model of MS-neuropathic pain are accompanied by attenuation of upregulated BDNF-TrkB-ERK signaling in the dorsal horn of the spinal cord | Q35822338 | ||
| The Angiotensin II Type 2 Receptor in Brain Functions: An Update | Q36520049 | ||
| Regulation of T-cell function by endogenously produced angiotensin II. | Q37100479 | ||
| Angiotensin II type 2 receptor (AT2 R) localization and antagonist-mediated inhibition of capsaicin responses and neurite outgrowth in human and rat sensory neurons | Q37108913 | ||
| Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor | Q37371633 | ||
| The angiotensin II type 2 (AT2) receptor: an enigmatic seven transmembrane receptor. | Q37410072 | ||
| Developmental Changes in Pain and Spinal Immune Gene Expression after Radicular Trauma in the Rat. | Q37503843 | ||
| AT(2) receptor and tissue injury: therapeutic implications | Q37531017 | ||
| How does angiotensin AT(2) receptor activation help neuronal differentiation and improve neuronal pathological situations? | Q38069825 | ||
| Analysis of the role of N-glycosylation in cell-surface expression and binding properties of angiotensin II type-2 receptor of rat pheochromocytoma cells | Q38287534 | ||
| Hopes for the Future of Pain Control | Q38679986 | ||
| Selective small molecule angiotensin II type 2 receptor antagonists for neuropathic pain: preclinical and clinical studies | Q38702811 | ||
| Analgesic efficacy and mode of action of a selective small molecule angiotensin II type 2 receptor antagonist in a rat model of prostate cancer-induced bone pain. | Q39033886 | ||
| Analgesic efficacy of small-molecule angiotensin II type 2 receptor antagonists in a rat model of antiretroviral toxic polyneuropathy | Q39211823 | ||
| Small molecule angiotensin II type 2 receptor (AT₂R) antagonists as novel analgesics for neuropathic pain: comparative pharmacokinetics, radioligand binding, and efficacy in rats | Q39230743 | ||
| Overcoming obstacles to developing new analgesics | Q39278452 | ||
| ERK1/2 mitogen-activated protein kinase phosphorylates sodium channel Na(v)1.7 and alters its gating properties | Q39744096 | ||
| Neurotrophic factor changes in the rat thick skin following chronic constriction injury of the sciatic nerve | Q40762287 | ||
| Evidence for a distinct neuro-immune signature in rats that develop behavioural disability after nerve injury | Q40926977 | ||
| Angiotensin II type 2-receptor: new clinically validated target in the treatment of neuropathic pain | Q41451854 | ||
| The marked disparity between the sizes of angiotensin type 2 receptors from different tissues is related to different degrees of N-glycosylation. | Q41464452 | ||
| Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization. | Q42468083 | ||
| Angiotensin II: from blood pressure to pain control | Q42706950 | ||
| A Pro-Nerve Growth Factor (proNGF) and NGF Binding Protein, α2-Macroglobulin, Differentially Regulates p75 and TrkA Receptors and Is Relevant to Neurodegeneration Ex Vivo and In Vivo | Q43121325 | ||
| Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury | Q45234435 | ||
| Effect of subpressor dose of angiotensin II on pain-related behavior in relation with neuronal injury and activation of satellite glial cells in the rat dorsal root ganglia | Q45708399 | ||
| Autonomic fibre sprouting and changes in nociceptive sensory innervation in the rat lower lip skin following chronic constriction injury | Q46524830 | ||
| Phosphorylation of sodium channel Na(v)1.8 by p38 mitogen-activated protein kinase increases current density in dorsal root ganglion neurons | Q46691815 | ||
| Phosphorylation sites on calcium channel alpha1 and beta subunits regulate ERK-dependent modulation of neuronal N-type calcium channels | Q46889147 | ||
| Expression of nerve growth factor in the dorsal root ganglion after peripheral nerve injury | Q47744359 | ||
| A small molecule angiotensin II type 2 receptor (AT₂R) antagonist produces analgesia in a rat model of neuropathic pain by inhibition of p38 mitogen-activated protein kinase (MAPK) and p44/p42 MAPK activation in the dorsal root ganglia. | Q48039050 | ||
| Immune cell involvement in dorsal root ganglia and spinal cord after chronic constriction or transection of the rat sciatic nerve. | Q48328700 | ||
| Nociceptor-like rat dorsal root ganglion neurons express the angiotensin-II AT2 receptor throughout development. | Q50478444 | ||
| trkA is expressed in nociceptive neurons and influences electrophysiological properties via Nav1.8 expression in rapidly conducting nociceptors. | Q50484843 | ||
| Local and remote immune-mediated inflammation after mild peripheral nerve compression in rats. | Q50903814 | ||
| Spinal translocator protein alleviates chronic neuropathic pain behavior and modulates spinal astrocyte-neuronal function in rats with L5 spinal nerve ligation model. | Q50942553 | ||
| Drug Repurposing for the Development of Novel Analgesics. | Q51316179 | ||
| Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury | Q56969314 | ||
| The mature/pro nerve growth factor ratio is decreased in the brain of diabetic rats: Analysis by ELISA methods | Q63213942 | ||
| Angiotensin AT(2) receptor stimulates ERK1 and ERK2 in quiescent but inhibits ERK in NGF-stimulated PC12W cells | Q73984943 | ||
| Regulatory T cells attenuate neuropathic pain following peripheral nerve injury and experimental autoimmune neuritis | Q84567367 | ||
| Finding the right antibody for the job | Q87170262 | ||
| Inflammation and nerve injury minimally affect mouse voluntary behaviors proposed as indicators of pain | Q89747137 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P304 | page(s) | 389 | |
| P577 | publication date | 2017-11-21 | |
| P1433 | published in | Frontiers in Molecular Neuroscience | Q27721913 |
| P1476 | title | Attenuation of the Infiltration of Angiotensin II Expressing CD3+ T-Cells and the Modulation of Nerve Growth Factor in Lumbar Dorsal Root Ganglia - A Possible Mechanism Underpinning Analgesia Produced by EMA300, An Angiotensin II Type 2 (AT2) Recept | |
| P478 | volume | 10 |
Search more.